Background: Baseline impedance measured with ambulatory impedance pH monitoring (MII-pH) and a mucosal impedance catheter detects gastroesophageal reflux disease (GERD). However, these tools are limited by cost or patient tolerance. We investigated whether baseline impedance measured during high-resolution impedance manometry (HRIM) distinguishes GERD patients from controls.
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| INTRODUCTION
Ambulatory reflux monitoring with pH or multichannel intraluminal impedance pH (MII-pH) is the current gold standard for the diagnosis of non-erosive gastroesophageal reflux disease (NERD). [1] [2] [3] It measures esophageal acid and non-acid exposure and calculates the strength of correlation of symptoms to the occurrence of reflux episodes. 4, 5 More recently this technology has been utilized indirectly to diagnose gastroesophageal reflux disease (GERD) by assessing esophageal epithelial integrity through baseline impedance measurement of the esophageal mucosa. This application is based on the common finding of dilation of the intercellular spaces (DIS) seen histologically in patients with NERD. [6] [7] [8] Dilation of the intercellular spaces presumably allow increased flow of ion rich fluid around the cells that is reflected by a decrease in impedance to current flow between adjacent catheter-based electrodes in contact with the esophageal surface epithelium. 9, 10 As a result, studies from different centers have documented that decreased baseline esophageal impedance is a reasonably accurate means of diagnosing NERD and correlates to DIS and measured decreases in mucosal permeability. [11] [12] [13] [14] [15] Nevertheless, the measurement of esophageal epithelial integrity by this method can be cumbersome. When using the MII-pH catheter, three 10 minute baseline periods during the night are averaged to calculate the mucosal impedance. 13, 15 There may be variation in these measurements, however, questioning the validity of this calculation.
Patients with prolonged nocturnal reflux episodes may also yield false positives, as low impedance measurements may be caused by intraesophageal fluid rather than abnormal epithelium. A catheter-based probe may also be used to directly measure baseline esophageal impedance, but this requires endoscopy and further standardization of how many areas of mucosa need to be assessed to arrive at a valid measurement. [16] [17] [18] [19] As a result, a shorter duration but less invasive test might be valuable in measuring esophageal epithelial permeability as a means of diagnosing NERD.
High-resolution esophageal manometry with impedance (HRIM)
has replaced standard esophageal manometry. With the addition of the impedance measurement, the transit of a swallowed bolus may be correlated with the pressure plots (Clouse plots) generated from esophageal pressure measurements. 20, 21 Nevertheless, as in the MII-pH catheter, the impedance probe with HRIM can theoretically also be used to reflect esophageal epithelial integrity. This is most likely to be accomplished during the attainment of baseline impedance measurement after an overnight fast and before water swallowing is started. The aim of this study was to correlate the baseline impedance measurement of an esophageal HRIM study to abnormal esophageal acid exposure and impedance measurements determined from MII-pH monitoring. 
| METHODS
| Patient selection
| Study design
| Baseline impedance measurement
Baseline impedance was measured during the landmark period of the HRIM study prior to initiation of study swallows ( Fig. 1A and B) . The impedance values in the most distal esophageal measuring segment (either 2 or 3 cm above the manometrically defined LES) were averaged over a 15 second period with the assistance of the Manoview software. Baseline impedance during MII-pH was measured as previously described. 13, 15 The impedance in the most distal esophageal impedance measuring segment (3 cm above the manometrically defined
Key Points
• Measurement of esophageal mucosal impedance may be a tool to diagnose GERD and avoid the time and patient intolerance of prolonged ambulatory pH monitoring.
However, esophageal mucosal impedance has only been measured during ambulatory pH/impedance studies or with an endoscopic impedance probe.
• In this study, baseline impedance measurement obtained at the beginning of routine HRIM demonstrated high diagnostic accuracy for GERD with excellent correlation with baseline impedance measured during HRIM and a 24 hour impedance pH study.
• Esophageal mucosal impedance determined with an HRIM catheter may provide an accurate and cost-effective tool for the diagnosis of GERD with the potential for superior patient acceptance. LES) was measured over three 10 minute intervals around 1, 2, and 3 a.m., respectively, utilizing the AccuView software. The mean of these measurements was then manually calculated. Time intervals for the measurement of baseline impedance were chosen based on the absence of impedance detected swallows or reflux events during the time period.
| Statistical analysis
Statistical analysis was done using JMP Abnormal bolus clearance, defined as incomplete impedance detected clearance in >20% of swallows, 23 was observed more commonly in GERD (23 (79%) patients) compared to controls (12 (46%) patients) (P=.01). on ROC analysis (Fig. 4) 
| RESULTS
| Patient characteristics
| Baseline impedance
| DISCUSSION
In this study, we demonstrated that: (i) baseline impedance measured during HRIM and MII-pH correlate, and (ii) HRIM measured baseline impedance correlates well with the presence of at least a moderate degree of esophageal acid exposure in patients with GERD.
Furthermore, the calculation of baseline HRIM impedance is easy to perform from readily available information on a standard HRIM study.
Similar to previous studies we found that baseline impedance mea- with measurements over 10 minute and 6 hour overnight periods. 13 Similarly, we found a positive correlation between baseline impedance measured during the 15 second landmark period of HRIM and the overnight period of MII-pH. In fact, the diagnostic accuracy of HRIM baseline impedance appeared possibly higher compared with measurement during the overnight period of MII-pH. This may be attributable to the fact that measurement during the landmark period of an HRIM study occurs while the patient is explicitly instructed not to swallow. This contrasts with MII-pH, in which periods of quiescence even during the overnight period, can be difficult to identify given transnasal catheter associated patient discomfort.
This study has several strengths. We identified a GERD cohort with marked predominant recumbent acid reflux to compare with a control group with a clear physiologic degree of esophageal acid exposure.
We defined GERD exclusively by acidic gastroesophageal reflux as conflicting data on the clinical relevance of impedance detected nonacid reflux exists. 1, 29 In addition, the dilation of intracellular spaces and resultant impairment of esophageal mucosal integrity is more likely to occur with nocturnal exposure to acidic content associated with increasing levels of epithelial injury. 7, 8 An additional strength of this study is that baseline impedance was measured during standard HRIM clinical studies. This broadens the clinical applicability of our findings and highlights the fact that baseline impedance can be assessed during HRIM as a part of current clinical practice.
The findings in this study are particularly promising as currently available diagnostic tools have significant limitations. MII-pH is limited by significant day to day variability 30 and the need for prolonged transnasal catheter placement. Furthermore, the clinical significance of abnormal degrees of non-acid impedance detected reflux remains unclear. 29 In contrast, the recent description of esophageal mucosal impedance as a diagnostic tool to assess clinical GERD has proven promising. 12, 13 Measurement of direct mucosal impedance using a single channel mucosal impedance catheter passed through the working channel of a standard upper endoscope has demonstrated remarkable diagnostic accuracy for GERD. [16] [17] [18] [19] and 1183 ohms, respectively (P=.3). We suspect that this is due to the fact that whether on or off PPI therapy, these patients had similar degrees of esophageal acid exposure (24% versus 18.5%, respectively, P=.3) and therefore likely similar degrees of dilated intracellular spaces.
There are also technical concerns over the reliability of the baseline impedance measurement. For example, could we be sure that the measurement was not reflecting swallowed or refluxed fluid? If this were the case, the impedance value would be close to zero and F I G U R E 5 Linear correlation between HRIM and MII-pH determined baseline impedance not at the levels measured. We also monitor carefully for swallows in the baseline manometry period which were not seen in these studies. Along the same line, four patients did have EGJ outflow obstruction, which could theoretically be complicated by esophageal stasis and potentially a lower measured baseline impedance.
However, three of the four patients with EGJ outflow obstruction were in the control group. Furthermore, structural evaluation with EGD and esophagram was normal in all four patients. Perhaps most importantly, symptoms and clinical response to therapy were not assessed in this study. Future studies to determine the correlation between symptomatic and asymptomatic patients and the response to medical therapy will be critical to validate the clinical utility of this diagnostic tool.
Nonetheless, we describe the successful application of baseline impedance measurement during HRIM in the assessment of GERD. Our results suggest HRIM determined baseline impedance has high diagnostic accuracy and can reliably distinguish moderately severe GERD patients from controls even in the absence of gross mucosal disease. Further we find that baseline impedance measured during a shorter HRIM study is comparable to that measured during a 24 hour MII-pH study. These results suggest that HRIM may offer an accurate, cost-effective, and relatively less invasive tool for the diagnosis of GERD with the potential for superior patient acceptance. Future studies determining the ability of baseline impedance measured during HRIM to diagnose all GERD patients and predict therapeutic response are needed.
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